Hao Fu

4.5k total citations · 2 hit papers
164 papers, 3.3k citations indexed

About

Hao Fu is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Hao Fu has authored 164 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 44 papers in Oncology and 33 papers in Biomedical Engineering. Recurrent topics in Hao Fu's work include Nanoplatforms for cancer theranostics (25 papers), Radiopharmaceutical Chemistry and Applications (14 papers) and Cancer-related Molecular Pathways (11 papers). Hao Fu is often cited by papers focused on Nanoplatforms for cancer theranostics (25 papers), Radiopharmaceutical Chemistry and Applications (14 papers) and Cancer-related Molecular Pathways (11 papers). Hao Fu collaborates with scholars based in China, United States and Singapore. Hao Fu's co-authors include Yaping Du, Yourong Duan, Zhong Liang, Yong Jiang, Haojun Chen, Chuanrong Chen, Chunlei Zhu, Jianlin Shi, Minghui Xiao and Linqi Shi and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and Nucleic Acids Research.

In The Last Decade

Hao Fu

151 papers receiving 3.2k citations

Hit Papers

Pt-Modified High Entropy Rare Earth Oxide for Efficient H... 2024 2026 2025 2024 2024 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hao Fu China 31 1.0k 794 738 476 437 164 3.3k
Jiandong Wang China 29 1.3k 1.3× 519 0.7× 553 0.7× 471 1.0× 670 1.5× 139 3.3k
Jianhua Wang China 22 682 0.7× 722 0.9× 699 0.9× 471 1.0× 213 0.5× 106 2.9k
Haitao Wu China 22 687 0.7× 492 0.6× 473 0.6× 280 0.6× 311 0.7× 158 2.3k
David M. Weinreich United States 20 685 0.7× 427 0.5× 453 0.6× 360 0.8× 275 0.6× 32 2.8k
Wiltrud Lederle Germany 30 784 0.8× 1.4k 1.8× 610 0.8× 351 0.7× 314 0.7× 63 3.1k
Hao Xing China 32 971 0.9× 638 0.8× 385 0.5× 212 0.4× 568 1.3× 154 2.9k
Kan Liu China 31 1.3k 1.2× 2.3k 2.8× 680 0.9× 379 0.8× 427 1.0× 168 4.2k
Jill Shea United States 21 712 0.7× 1.1k 1.3× 554 0.8× 349 0.7× 249 0.6× 70 2.6k
Jun Qian China 28 1.9k 1.8× 514 0.6× 448 0.6× 199 0.4× 436 1.0× 113 3.5k

Countries citing papers authored by Hao Fu

Since Specialization
Citations

This map shows the geographic impact of Hao Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Fu more than expected).

Fields of papers citing papers by Hao Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Fu. The network helps show where Hao Fu may publish in the future.

Co-authorship network of co-authors of Hao Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Fu. A scholar is included among the top collaborators of Hao Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Fu. Hao Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lv, Shuyi, Cheng Wang, Hao Fu, et al.. (2025). Synergistic Eradication of Bacterial Biofilms via Phage‐Driven EPS Disruption and Click‐Activated AIE Photosensitization. Advanced Healthcare Materials. 14(32). e02295–e02295.
2.
Fu, Hao, Liang Zhao, Weizhi Xu, et al.. (2025). 177Lu-LNC1004 Radioligand Therapy in Patients with End-stage Metastatic Cancers: A Single-Center, Single-Arm, Phase II Study. Clinical Cancer Research. 31(8). 1415–1426. 13 indexed citations
3.
Zhao, Liang, Yizhen Pang, Yi Ding, et al.. (2025). 68Ga-NK224 PET/CT for Noninvasive Evaluation of PD-L1 Expression and Intertumor Heterogeneity: A Translational Exploratory Study. Clinical Cancer Research. 31(14). 2989–3001. 3 indexed citations
4.
Guo, Wei, Weizhi Xu, Tinghua Meng, et al.. (2025). FAP-targeted PET/CT imaging in patients with breast cancer from a prospective bi-center study: insights into diagnosis and clinic management. European Journal of Nuclear Medicine and Molecular Imaging. 52(7). 2317–2334. 4 indexed citations
5.
Fu, Hao, Qian Huang, & Jungang Xie. (2025). Targeting Regulated Cell Death Pathways in COPD: Mechanisms and Therapeutic Strategies. Cells. 14(23). 1874–1874.
6.
Sun, Zhencheng, Jiaxin Wang, Minghui Xiao, et al.. (2024). A straightforward strategy to modulate ROS generation of AIE photosensitizers for type-I PDT. Chemical Engineering Journal. 499. 155782–155782. 12 indexed citations
7.
Sun, Zhencheng, Minghui Xiao, Shuyi Lv, et al.. (2024). A pH‐Responsive, Surface Charge‐Switchable Nanosystem with Enhanced Biofilm Penetration for Synergistic Photodynamic and Antibiotic Therapy of Diabetic Wounds. Advanced Functional Materials. 35(17). 9 indexed citations
8.
Fu, Hao, Yongxin Zhang, Cheng Wang, et al.. (2024). A universal strategy to enhance photothermal conversion efficiency by regulating the molecular aggregation states for safe photothermal therapy of bacterial infections. Biomaterials Science. 12(11). 2914–2929. 8 indexed citations
9.
10.
Xiao, Minghui, Ke Xue, Hao Fu, et al.. (2024). Photodynamic patterning of living bacterial biofilms with high resolutions for information encryption and antibiotic screening. SHILAP Revista de lepidopterología. 5(4). 12 indexed citations
11.
Li, Ping, Hao Fu, Xiaoyang Feng, et al.. (2023). A dummy molecularly imprinted ratiometric fluorescence nanosensor for the sensitive detection of guanidyl-microcystins in environmental water. The Analyst. 148(3). 573–582. 11 indexed citations
12.
Fu, Hao, Tianzhi Zhao, Hongjian Wang, et al.. (2023). Fibroblast Activation Protein-Targeted Radioligand Therapy with 177Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose-Escalation Study. Clinical Cancer Research. 29(23). 4740–4750. 56 indexed citations
13.
Fu, Hao, Ke Xue, Yongxin Zhang, et al.. (2023). Thermoresponsive Hydrogel‐Enabled Thermostatic Photothermal Therapy for Enhanced Healing of Bacteria‐Infected Wounds. Advanced Science. 10(11). e2206865–e2206865. 97 indexed citations
14.
Jiang, Han, Hao Fu, Yuedong Guo, Ping Hu, & Jianlin Shi. (2022). Evoking tumor associated macrophages by mitochondria-targeted magnetothermal immunogenic cell death for cancer immunotherapy. Biomaterials. 289. 121799–121799. 75 indexed citations
15.
Li, Ping, Hao Fu, Xiaoyang Feng, et al.. (2022). Fluorescence and electrochemical integrated dual-signal sensor for the detection of iron ions in water based on an ITO substrate. The Analyst. 147(20). 4489–4499. 4 indexed citations
16.
Chen, Chuanrong, Qianqian Guo, Hao Fu, et al.. (2021). Asynchronous blockade of PD-L1 and CD155 by polymeric nanoparticles inhibits triple-negative breast cancer progression and metastasis. Biomaterials. 275. 120988–120988. 61 indexed citations
17.
Fu, Hao, Ming Shen, Hong Xu, et al.. (2019). Strategy to prevent cardiac toxicity induced by polyacrylic acid decorated iron MRI contrast agent and investigation of its mechanism. Biomaterials. 222. 119442–119442. 11 indexed citations
19.
Lu, Zhonglei, Frederick Bauzon, Hao Fu, et al.. (2016). p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer. Oncogene. 36(1). 60–70. 24 indexed citations
20.
Chen, Ke‐Neng, Hao Fu, Zhitao Gu, et al.. (2015). P01: Long-term survival after surgical treatment of thymic carcinoma.. Journal of Thoracic Disease. 7(3). 1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026